Long noncoding RNA (lncRNA) H19 is abundantly expressed in fetal liver. Its expression is significantly diminished in adult healthy liver but is re-induced in chronic liver diseases, including cholestasis. In this study, we developed a new method with combined in situ hybridization (ISH) and immunofluorescence (IF) colabeling to establish an H19 expression profile with both parenchymal and nonparenchymal cell-specific markers in the livers of cholestatic mouse models and patients with cholestasis. 
L ong noncoding RNAs (lncRNAs), defined as a nonprotein-coding transcript of more than 200 nucleotides in length, are highly abundant in mammalian species.
(1) It has been estimated there are 14,880 lncRNA transcripts in the human genome, (2) but the number could be much higher. (3) Even with lower expression levels compared with messenger RNA, (2, 4) lncRNAs play a vital role in various cellular processes in both physiologic and pathologic conditions. (5) They hold important roles in regulating the expression and function of global-or local-coding genes, and their aberrant expression could lead to diseases in diverse organs. (6) H19 is a paternal-imprinted lncRNA that is 2.3 kb in length; it is highly expressed in embryonic liver but markedly reduced after birth and in adult liver.
(7) Due to its high expression level in fetal liver, it is postulated that H19 is an important gene in regulating liver development, but the mechanism remains elusive. Liver is the only organ with a strong ability to regenerate. (8) After partial hepatectomy (PH), H19 was increased in hepatocytes isolated from experimental mouse liver, (9) indicating that the re-activated H19 was associated with promoting liver regeneration. Recent studies have also observed increased H19 expression in patients with chronic liver diseases, including liver cancer, (10) cholestatic liver injury, (7) liver fibrosis and cirrhosis, (11) PBC, and PSC. (12) Overexpression of H19 in mouse hepatocytes augmented liver injury induced by BDL and DDC. These observations indicate an important role of H19 in liver disease.
Despite recent progress on the hepatic function of H19, its cell-type-specific expression profile in liver remains controversial. Current knowledge about H19 expression is based on quantitative reverse-transcription polymerase chain reaction (PCR) analysis in isolated primary cells from animal models. A major limitation of this method is that the isolated primary cells are likely contaminated with neighboring cells, thereby producing false positives. Indeed, discrepant results have been reported. H19RNA was highly expressed in isolated hepatocytes at day 3 after PH in one study, (9) whereas another study reported that H19RNA was mainly expressed in primary cholangiocytes and was not expressed in hepatocytes or Kupffer cells. (13) There is an urgent need to develop a new method to precisely localize the subcellular distribution of H19, especially in human liver specimens.
In this study, we established a novel in situ method to directly detect H19RNA and colocalize it with celltype-specific markers in mouse models of cholestatic liver fibrosis and in human PBC and PSC specimens. We found that H19RNA was not expressed in CK19 + cholangiocytes but was exclusively expressed in cytoplasm that partially overlapped with HNF4α + hepatocytes, SOX9
+ progenitor cells, and F4/80 + Kupffer cells in periportal areas; it was also found at the interspace between neighboring cells or translocated into the nucleus under severe cholestatic conditions. Our findings are of critical importance to guide future research to further understand the role of H19 in liver metabolic diseases.
Materials and Methods

animals anD Human liVeR speCimens
Mouse models included maternal H19-deleted mice (Mat -/-) with paternal H19-deleted mice (Pat -/-) as control, as described. (12, 14) Mice were provided with free access to a standard rodent chow diet (Harlan No. 2018) and water and housed in a temperature-controlled (23°C) and pathogen-free facility aRtiCle inFoRmation:
with a 12-hour light/dark cycle. BDL surgeries were performed on 6-week-old male mice for 1 week as described. (15) Cholestatic liver injury was also induced with a DDC-containing diet as described. (16) 
Mdr2
-/-mice have been described. (17) Animal studies complied with the guidelines of the Institutional Animal Care and Use Committee of the University of Connecticut.
The coded liver specimens PBC and PSC were obtained through the Liver Tissue Cell Distribution System (National Institutes of Health contract no. HSN276201200017C) as described. (12) Because we did not ascertain individual identities associated with the samples, the Institutional Review Board for Human Research at the University of Connecticut determined that this project was not research involving human subjects.
H19 isH ComBineD WitH iF staining
Liver samples were processed in formalin for 48 hours followed by embedding in paraffin. We cut 4-µm sections for staining and performed H19 ISH following instructions in the RNAscope Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics). For combined staining, pretreatment durations were optimized based on different cell markers. IF staining was performed before incubating liver sections with 4',6-diamidino-2-phenylindole (DAPI). Briefly, liver sections were washed with distilled water and phosphate-buffered saline (PBS) twice each, followed by blocking in 10% goat serum in PBS with 0.1% Triton X-100, then incubated with primary antibodies against different cell types (Table 1 ) at 4°C overnight. On the following day, liver sections were incubated with fluorescent-conjugated goat anti-mouse/rabbit secondary antibody (Table 1 ) at room temperature for 1 hour after three washes in PBS with 0.1% Triton X-100. After another three washes, liver sections were stained with DAPI and mounted. Images were taken under a confocal microscope using fluorescence microscopy (Leica SP8).
Rna isolation anD Real-time pCR
Total RNAs from human specimens were isolated by TRIzol (Ambion), and the complementary DNA (cDNA) library was synthesized using the HighCapacity cDNA Reverse Transcription Kit (Thermo Fisher) according to the manufacturer's protocol. (18) Universal SYBR Green (Bio-Rad Laboratories) was used for quantitative PCR. (16) Primers used for human H19 were TGGTGCACTTTACAACCACTG (forward) and ATGGTGTCTTTGATGTTGGGGC (reverse); human glyceraldehyde 3-phosphate dehydrogenase was used for normalization.
statistiCal analysis
Data were expressed as mean ± SEM and represented by triplicate assays. Statistical analysis was performed using one-way analysis of variance among multiple groups and the Student t test between two groups. (19) P < 0.05 was considered statistically significant.
Results
H19Rna is pReDominately eXpResseD in Cytoplasm anD Can Be seCReteD into neigHBoRing Cells
H19 is a paternal-imprinted gene; therefore, Pat -/-were used as wild-type mice and Mat -/-were used as H19 knockout mice (negative controls). Because H19RNA is barely detectable in adult normal liver, we could perform H19 staining in sham mice. H19 was induced in cholestasis (7) ; thus, BDL liver sections were used for the initial analysis. We first tested RNA quality in formalin-fixed paraffin-embedded (FFPF) mouse liver sections by using both negative-mouse bacterial gene dapB and positive-mouse peptidylprolyl isomerase B probes supplied from the RNAScope Assay kit following the manufacturer's instructions. No green fluorescence signals were detected using the negative-control probe, whereas strong punctate green dots were detected by the positive-control probe (Supporting Fig. S1 ). In addition, no H19RNA was detected in Mat -/--BDL and Mat -/--sham liver (Supporting Fig. S2 ). In contrast, H19RNA-positive cells were detected in Pat -/--BDL liver in fibrosis areas (Supporting Fig. S3A , yellow arrow) and were also found close to the portal vein (Supporting Fig. S3B , yellow arrow) adjacent to the bile duct (Supporting Fig. S3B , red arrow). We note that H19RNA was exclusively expressed in cytoplasm with a punctate staining pattern (Supporting Fig. S4A , yellow arrow). It was also found between cells (Supporting Fig. S4B , orange arrow), indicating a likelihood of secretion into neighboring cells. Future studies will determine how the H19 secretion occurs.
H19Rna is not eXpResseD in CK19
+ oR epitHelial Cell aDHesion moleCule +
CHolangioCytes But may ResiDe in Canals oF HeRing lineD By HepatoCytes in tHe BDl mouse moDel
Based on prior findings that H19 promoted BDLinduced bile duct epithelial cell (i.e., cholantiocyte) proliferation, (20) we first costained H19RNA with the biliary epithelial cell marker CK19. Immunostaining for CK19 labeled a single cell, cell cluster, or string surrounding the bile ducts in response to bile duct damage (ductular reaction [DR]) (Fig. 1A) . However, none of the H19RNA + (green)-positive cells overlapped with CK19 + (red)-positive cholangiocytes. Interestingly, H19RNA + cells were found at the interphase of bile duct and hepatocyte plates in small numbers near the bile ducts and were clearly distinguishable from neighboring hepatocytes. These cells did not reside in but were immediately adjacent to biliary structures ( Epithelial cell adhesion molecule (EpCAM) is another cholangiocyte marker that is expressed around the portal vein in wild-type mice. (21) EpCAM stain of human hepatitis B cirrhosis showed cytoplasmic staining of biliary structures. (22) DRs, inclusive of intermediate cells, showed some cytoplasmic staining but also membranous staining. The hepatocytes surrounding the DRs showed extensive membranous staining. Interestingly, we observed membranous staining of EpCAM in the DRs (Supporting Fig. S6 Fig. 2B; Supporting Fig. S9 , red circle). Most mature HNF4α + hepatocytes were not colabeled with H19RNA; thus, H19 was only expressed in a specific population of hepatocytes that were also positive for Fig. 3A; Supporting Fig. S11A ). Interestingly, in some cells, both H19RNA and F4/80 were completely overlapped in a vesicle structure that was attached to or immediately adjacent to the nucleus ( Fig. 3B; Supporting Fig. S11B, white arrowhead) . We also observed single H19RNA + (yellow arrow) and single F4/80 + (red arrow) cells (Supporting Fig. S12 ). Because F4/80 can mark both resident Kupffer cells and infiltrating macrophages, H19 could be expressed in both cell populations. The results are in agreement with a recent report showing that hepatic overexpression of H19 enriched immune cell populations in liver and spleen. (12) H19Rna is not eXpResseD in Desmin + stellate Cells in tHe BDl mouse moDel Hepatic stellate cells are collagen-producing cells in the liver that are responsible for fibrogenesis in chronic liver diseases. Encouraged by the above results that H19RNA was detected in F4/80 Kupffer cells, we next assessed its expression in hepatic stellate cells. Direct fluorescence of H19RNA (green) with immunostaining for the mesenchymal cell marker desmin (red) showed no colocalization of either gene (Fig. 3C) . Prior studies revealed co-IF of CK19 and desmin of ductular structures within the portal field. (24) We found high labeling efficiency of desmin + periportal mesenchymal cells in DRs. Colabeling with α-smooth muscle action (α-SMA) also failed to detect the presence of H19RNA in α-SMA + cells (not shown). Together these results argue against a contribution from resident mesenchymal cells to H19RNA + progenitor cells.
H19Rna is not eXpResseD in CK19 + CHolangioCytes in DDC oR Mdr2
-/-mouse moDels oF
BiliaRy liVeR FiBRosis
The liver toxin DDC-enriched diet is commonly used as a chemically induced chronic cholestatic liver injury model with a strong expansion of atypical ductal proliferation near the periportal areas. (24) To expand our findings from the above BDL model, we examined H19RNA in DDC-fed mouse liver. Similarly, H19RNA did not overlap but was in close proximity to CK19 + cells ( Fig. 4A; Supporting Fig. S13 ). Mdr2 (Abcb4) -/-mice spontaneously develop hepatic lesions resembling PSC, representing one of the best characterized biliary fibrosis models of cholangiopathy. (25) We examined H19RNA in 3-month-old male Mdr2
-/-and 7-month-old female Mdr2 -/-livers.
H19RNA was barely detectable in 3-month-old male Mdr2 -/-liver (Supporting Fig. S14 ). In contrast, H19RNA was highly induced in cells adjacent to the DRs (Supporting Fig. S15A ) and in periportal regions (Supporting Fig. S15B ) in 7-month-old female Mdr2 -/-liver. Consistent with the results in BDL and DDC livers, H19RNA was not expressed in CK19 + cholangiocytes in 7 month-old female Mdr2 -/-liver ( Fig. 4B; Supporting Fig. S16 ). Fig. 4C; Supporting  Fig. S17 ). We found that the H19RNA signal overlaid with the nucleus in some cells, likely due to its remarkable induction (Supporting Fig. S17, yellow circle ).
H19Rna is eXpResseD in
An extracellular H19RNA signal was also observed (orange circle), indicative of its secretion.
Because triple H19RNA + /HNF4α + /SOX9 + periportal hepatocytes were observed in the BDL mouse model as presented above, we costained these three genes in 7-month-old female Mdr2 -/-liver. SOX9 + (white) cells were abundantly observed around the DRs ( Fig. 4D; Supporting Fig. S18) -/-models.
H19Rna is not eXpResseD in matuRe CK19
+ CHolangioCytes in Human pBC oR psC liVeR speCimens PBC and PSC are two main human cholangiopathies. (26) PBC is a chronic progressive cholestatic liver disease characterized by inflammatory obliteration of the intrahepatic bile ducts, leading to fibrosis and ultimately to cirrhosis complicated by liver failure or hypertension. (27) PSC is another chronic liver disease characterized by intrahepatic and extrahepatic duct inflammation and fibrosis, is associated with inflammatory bowel diseases, and ultimately leads to biliary cirrhosis in advanced stages. (28) To determine sex disparity, we determined H19RNA in both male and female PBC and PSC liver specimens (Supporting Table S1 ). Interestingly, the levels of H19RNA were significantly elevated in female but not male PBC and in male but not female PSC, as compared to normal controls (Supporting Fig. S19 ). Based on these results, we selected two female PBC and two male PSC samples with high H19RNA expression for further analysis. We first tested RNA quality in FFPF human liver sections by using both negative human bacterial gene dapB and positive human peptidylprolyl isomerase B probes. No green fluorescence signals were detected using the negative-control probe, whereas strong punctate green dots were detected by the positive-control probe (Supporting Fig. S20 ).
As expected, H19RNA was markedly induced in female PBC livers (Supporting Figs. S21 and S22) . Despite being located in close proximity, H19RNA did not overlap with mature CK19 + cholangiocytes in bile ducts (Fig. 4E, top panel) . H19RNA was diffuse in the nucleus (orange arrow), which could indicate either nuclear translocation from cytoplasm or newly synthesized RNAs that have not been completely translocated into cytoplasm due to the extremely high expression of H19RNA.
Similarly, H19RNA was markedly induced in male PSC livers and did not overlap with mature CK19 + cholangiocytes in biliary structures (Supporting Figs.  S23 and S24) . Some H19RNA signals, however, were dispersed into individual neighboring cells positive for CK19 + (Fig. 4E, bottom panel, white arrow) . These cells may represent the newly regenerated immature cholangiocytes from DRs or may represent bipotential liver progenitor cells.
H19Rna is eXpResseD in HnF4α
+ HepatoCytes in Human pBC anD psC liVeR speCimens H19RNA was found expressed in HNF4α + hepatocytes in both female PBC and male PSC liver specimens (76.6% and 74.5%, respectively) ( Fig. 4F;  Supporting Fig. S25 ). In addition to its nuclear localization in hepatocytes, HNF4α was highly expressed in the cytoplasmic compartment in DR and fibrotic areas (white arrow). Prior studies showed cytoplasmic expression of HNF4α messenger RNA in ductular hepatocytes in massive necrosis areas. (29) The subcellular localization of HNF4α could be associated with its phosphorylation status. (30) Because HNF4α is a critical master transcriptional regulator of liver function, its cytoplasmic retention will affect the expression of its target genes and consequently hepatic homeostasis during cholestatic liver injury. Taken together, H19RNA was colocalized with HNF4α protein in mature hepatocytes in PBC and PSC specimens.
Discussion
The conventional RNA ISH technique is difficult to perform and lacks sensitivity and specificity, especially in measuring RNA that is in low abundance. (31) Fluorescent labeling is a sensitive method broadly used in research and has the advantage of a multiple-label possibility for detecting more than one target signal simultaneously. The recently developed RNAscope employs new strategies in designing probes and amplifying signals (32) ; however, this technique can only detect RNA. Zimmerman et al. (33) set up a combined IF and fluorescent ISH labeling approach in Drosophila ovaries by performing IF before fluorescent ISH. However, this approach was complicated and took 5 days to complete. Our new method used the advantage of RNAscope to obtain high-quality H19RNA signals and followed this by high-resolution IF staining of protein markers; this was easy to perform, had a shorter duration time, and was reproducible with very reliable outcomes.
Using the above new method, we directly visualized the localization of H19RNA in cholestatic livers. We found the following: 1) H19RNA was predominately detected in the cytoplasm of cells but also at the interspace with neighboring cells under severe cholestatic conditions; 2) in contrast, H19RNA was not detected in CK19
+ cholangiocytes but likely resides in CoH lined by hepatocytes; 3) H19RNA was partially colocalized with HNF4α + hepatocytes, SOX9 + progenitor cells, and F4/80 + Kupffer cells in periportal areas; and 4) H19RNA was not expressed in desmin + stellate cells. Importantly, we identified significant enrichments of H19RNA in hepatocytes in a subset of female PBC and male PSC livers, signifying the importance of H19 in human biliary liver fibrosis.
Liver contains two major types of cells: parenchymal cells, which include hepatocytes and cholangiocytes, and nonparenchymal cells, which include sinusoidal endothelial, Kupffer, and stellate cells. (34) Hepatic bile acid homeostasis is tightly controlled by transcriptional regulators. (17) Dysregulation of bile synthesis or bile flow results in cholestasis and liver injury, which are often accompanied with striking morphologic changes. (31) In particular, periportal bile ductules and CoH are constantly injured by inflammatory cells, resulting in CK19-positive reactions. Cells in DRs are phenotypically heterogeneous, expressing transcription factors as well as surface and cytoplasmic markers, including CK19 and SOX9, for stem/progenitors. Recent studies indicate that EpCAM could serve as a hepatic stem/progenitor cell-specific marker. (35) In liver biopsy specimens from patients with chronic hepatitis B and C, EpCAM + hepatocytes were rare in early stages of disease, became increasingly prominent in later stages in parallel with the emergence of DRs, and were consistently arrayed around the periphery of cords of CK19 + hepatobiliary cells of the DRs with which they shared EpCAM expression. (22) In human liver, hepatic stem/progenitor cells can be isolated by immune selection for EpCAM. (22) In the present study, we did not identify H19RNA + cells overlapping with either CK19 + or EpCAM + ductal cells, suggesting that H19RNA is not expressed in this cell population that composes or generates cholangiocytes. Interestingly, H19RNA was not found in all segments of the biliary tree but in areas near small ducts, suggesting its unique expression activation by unknown signaling molecules.
Our results argue against a recent study by Li et al. (36) showing that H19RNA is mainly expressed in primary cholangiocytes and that cholangiocyte-derived exosomal H19 promotes cholestatic liver injury by suppressing the small heterodimer partner in hepatocytes. A potential explanation for this discrepancy could be the contamination of CK19 + /H19RNA -cholangiocytes from CK19 -/H19RNA + neighboring cells during cholangiocyte isolation, as it would be technically challenging to separate both cell populations due to their close proximity. H19 was also reported to be induced by bile acids in the mouse small cholangiocyte cell line (MSC). (12) MSC was derived from cholangiocytes isolated from small ducts that may have acquired certain characteristic changes with stem-like features during immortalization that are not present in primary cholangiocytes. Removing cells from their in vivo environment may also confer properties of plasticity not representative of in vivo biology, which likely contributes to the difference in results. Cell signaling can take place either through direct cell-cell contacts or through the action of secreted signaling molecules. In paracrine signaling, a molecule released by one cell acts on neighboring target cells. Due to the close vicinity of H19RNA + cells to CK19 + cholangiocytes, we postulate that H19 may act as a local signaling molecule to regulate the behavior of nearby cholangiocytes. It should also be noted that liver H19 is highly induced in female Mdr2 -/-mice, an animal model of human PSC; however, it is highly induced in PBC female and PSC male livers. The results suggest that the sex dimorphic regulation of H19 may be different in mice and humans. The pathways that contribute to increased H19 expression in PBC and PSC remain to be determined in future studies.
Most hepatic injuries, such as surgical PH, result in a progenitor-independent proliferative response of preexisting mature cells. However, other forms of liver damage can induce progenitor-dependent liver regeneration. This process is considered to involve the emergence of a new epithelial cell type not present in normal liver, termed "hepatic oval cell." The cellular origin of oval cells is unknown, but it is hypothesized that oval cells are the progeny of resident adult hepatic stem cells. (35) Liver stem cells (LSCs) are viewed as bipotential nonhepatocyte precursors of highly proliferative progenitor cells that can differentiate into either hepatocytes or biliary epithelial cells. However, using genetic fate tracing in adult mice fed a cholinedeficient ethionine-supplemented diet, Schaub et al. (37) failed to provide evidence for hepatocytes derived from LSCs or other nonhepatocyte cell types, which argues against the notion that LSCs replenish lost hepatocytes during liver regeneration. Conflicting results have been reported about the identity of LSCs. Recent reports in adult mice showed two distinct subpopulations of hepatocytes, namely "Axin2 + " cells located pericentrally (24) and "SOX9 + hybrid periportal hepatocytes" located periportally within the liver lobule. (25) During liver maturation, multiple stem cell niches persist in specific anatomical locations within adult liver, including biliary tree stem/progenitor cells in peribiliary glands along extrahepatic and large intrahepatic bile ducts and hepatic stem/progenitors in or near CoH. (23) It would be interesting to determine the origin of H19RNA + cells during liver development in future studies using lineage tracing. Identifying new factors that stimulate proliferation and differentiation of hepatic stem cells in response to liver injury are of interest for the development of cell-based therapies in cholestatic liver fibrosis.
In conclusion, we successfully developed a new combined ISH+IF costaining method that is simple and reliable for determining cell-type-specific H19 localization. By costaining with hepatic cell-specific markers, we uncovered that H19RNA is not expressed in CK19+ cholangiocytes but in HNF4α + hepatocytes immediately adjacent to biliary structures in different cholestatic mouse models and human specimens. We also revealed that H19RNA can be secreted into neighboring cells, providing a solid foundation to investigate the mechanisms by which H19 regulates cholangiocyte proliferation and liver fibrosis, likely through cell-cell communication in a paracrine fashion. Future studies are warranted to identify endogenous signaling pathways that induce H19 expression during the progression of cholestasis.
